Dineika Chandrananda

2.6k total citations
16 papers, 653 citations indexed

About

Dineika Chandrananda is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dineika Chandrananda has authored 16 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dineika Chandrananda's work include Cancer Genomics and Diagnostics (14 papers), Lung Cancer Treatments and Mutations (5 papers) and Genetic factors in colorectal cancer (4 papers). Dineika Chandrananda is often cited by papers focused on Cancer Genomics and Diagnostics (14 papers), Lung Cancer Treatments and Mutations (5 papers) and Genetic factors in colorectal cancer (4 papers). Dineika Chandrananda collaborates with scholars based in United Kingdom, Netherlands and Australia. Dineika Chandrananda's co-authors include Nitzan Rosenfeld, Florent Moulière, Christopher G. Smith, Natalie Thorne, Melanie Bahlo, Francesco Marass, James Morris, Dana W.Y. Tsui, Colin Watts and Kevin M. Brindle and has published in prestigious journals such as The Lancet, Nature Communications and Bioinformatics.

In The Last Decade

Dineika Chandrananda

15 papers receiving 645 citations

Peers

Dineika Chandrananda

PRM

ONCOL

SURGE

Elisa Schipper Germany

Émilie Consolino France

Ingrid P. Vogelaar Netherlands

Sabine Weickmann Germany

Claudia Augello Italy

Tse Hui Lim Singapore

Ninad Dewal United States

Roz Brant United Kingdom

A S Yang United States

Muriel Belotti Italy

Elisa Schipper Germany

Dineika Chandrananda

365 ×0.7

405 ×1.3

61 ×0.3

PRM

101 ×0.5

ONCOL

28 ×0.3

SURGE

Citations per year, relative to Dineika Chandrananda Dineika Chandrananda (= 1×) peers Elisa Schipper

Countries citing papers authored by Dineika Chandrananda

Since Specialization

Citations

This map shows the geographic impact of Dineika Chandrananda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dineika Chandrananda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dineika Chandrananda more than expected).

Fields of papers citing papers by Dineika Chandrananda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dineika Chandrananda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dineika Chandrananda. The network helps show where Dineika Chandrananda may publish in the future.

Co-authorship network of co-authors of Dineika Chandrananda

This figure shows the co-authorship network connecting the top 25 collaborators of Dineika Chandrananda. A scholar is included among the top collaborators of Dineika Chandrananda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dineika Chandrananda. Dineika Chandrananda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hollizeck, Sebastian, Stephen Q. Wong, Sarah Ftouni, et al.. (2024). Unravelling mutational signatures with plasma circulating tumour DNA. Nature Communications. 15(1). 9876–9876. 1 indexed citations

Brasacchio, Daniella, et al.. (2024). mirrorCheck: an R package facilitating informed use of DESeq2’s lfcShrink() function for differential gene expression analysis of clinical samples. Bioinformatics Advances. 5(1). vbaf070–vbaf070.

Pol, Ymke van der, Norbert Moldován, Jip Ramaker, et al.. (2023). The landscape of cell-free mitochondrial DNA in liquid biopsy for cancer detection. Genome biology. 24(1). 229–229. 25 indexed citations

Markus, Havell, Dineika Chandrananda, Elizabeth Moore, et al.. (2022). Refined characterization of circulating tumor DNA through biological feature integration. Scientific Reports. 12(1). 1928–1928. 33 indexed citations

Hudecova, Irena, Christopher G. Smith, Robert Hänsel‐Hertsch, et al.. (2021). Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA. Genome Research. 32(2). 215–227. 58 indexed citations

Hollizeck, Sebastian, Stephen Q. Wong, Benjamin Solomon, Dineika Chandrananda, & Sarah‐Jane Dawson. (2021). Custom workflows to improve joint variant calling from multiple related tumour samples: FreeBayesSomatic and Strelka2Pass. Bioinformatics. 37(21). 3916–3919. 1 indexed citations

Ahlborn, Lise Barlebo, Gitte Fredberg Persson, Dineika Chandrananda, et al.. (2020). Circulating cell free DNA during definitive chemo-radiotherapy in non-small cell lung cancer patients – initial observations. PLoS ONE. 15(4). e0231884–e0231884. 14 indexed citations

Mair, Richard, Florent Moulière, Christopher G. Smith, et al.. (2018). Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models. Cancer Research. 79(1). 220–230. 68 indexed citations

Tsui, Dana W.Y., Heather Biggs, Sarah‐Jane Dawson, et al.. (2018). Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients. Journal of Molecular Diagnostics. 20(6). 883–892. 84 indexed citations

10.

Moulière, Florent, Richard Mair, Dineika Chandrananda, et al.. (2018). Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO Molecular Medicine. 10(12). 117 indexed citations

11.

Tsui, Dana W.Y., Muhammed Murtaza, Alvin Wong, et al.. (2018). Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer. EMBO Molecular Medicine. 10(6). 52 indexed citations

12.

Patel, Keval, Kristan E. van der Vos, Christopher G. Smith, et al.. (2017). Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer. Scientific Reports. 7(1). 5554–5554. 84 indexed citations

13.

Wan, Jonathan C. M., Suzanne Murphy, Davina Gale, et al.. (2017). Individualised monitoring of patients with metastatic melanoma using plasma DNA. The Lancet. 389. S99–S99. 1 indexed citations

14.

Ruiz-Valdepeñas, Andrea, Katrin Heider, Wendi Qian, et al.. (2017). MA 11.02 Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update. Journal of Thoracic Oncology. 12(11). S1843–S1844. 2 indexed citations

15.

Chandrananda, Dineika, Natalie Thorne, & Melanie Bahlo. (2015). High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. BMC Medical Genomics. 8(1). 29–29. 92 indexed citations

16.

Chandrananda, Dineika, Natalie Thorne, Devika Ganesamoorthy, et al.. (2014). Investigating and Correcting Plasma DNA Sequencing Coverage Bias to Enhance Aneuploidy Discovery. PLoS ONE. 9(1). e86993–e86993. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact